×

Tricyclic fused thiophene derivatives as JAK inhibitors

  • US 9,181,271 B2
  • Filed: 10/31/2013
  • Issued: 11/10/2015
  • Est. Priority Date: 11/01/2012
  • Status: Active Grant
First Claim
Patent Images

1. A compound, which is ((2R,5S)-5-{2-[(1R)-1-hydroxyethyl]-1H-imidazo[4,5-d]thieno[3,2-b]pyridin-1-yl}tetrahydro-2H-pyran-2-yl)acetonitrile, or a pharmaceutically acceptable salt thereof.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×